Akinlo, Ambrose, Adeleke Bisiriyu, and Olapeju Esimai
1
Al Moosawi, S.
1
Alice Mark
1
Aliku, T. et al.
1
Alipanah N, Jarlsberg L et al.
1
Allach, Y.
1
Alvarado R., Ramírez J. et al
1
Amini, M.
1
Anaya-Covarrubias, J.Y.
1
and J. Garcia-Rosales Delgado
1
Armstrong, G.
1
Aye Kyawt Paing et al.
1
B. Ezenwa
1
B.S. Kamps
1
Banerjee, A.
1
Bapoutou, B.
1
Bazargani, Y.T.
1
Bălă, G.P.
1
Begum, T. S. M.
1
Bennett, James et al.
1
Berry, P.
1
Betrò, S.
1
BMC
1
BMC Cardiovascular Disorders
1
BMC Infectious Diseases
1
BMJ Open
1
Bo Peng , Rowland W. Pettit, and Christopher I. Amos
1
Bo Wen, Rongbin Xu, Yao Wu, Micheline de Sousa Zanotti Stagliorio Coelho et al.
1
Bodeker, Gerard, Ong, Chi-Keong, Grundy, Chris, Burford, Gemma, Shein, Kin. et al. (2005). WHO global atlas of traditional, complementary and alternative medicine. Kobe, Japa
1
Bozorgmehr, K.
1
Braae, U.
1
Breitner-Busch, S.
1
Bundeszentrale für gesundheitliche Aufklärung
1
C. C. Onyedum, I. Alobu, K. N. Ukwaja
1
C. Contini, M. Maritari, M. die Nuzzo, et al.
1
C. Hoffmann, A. Gualani Gualani
1
C. Hoffmann, et al.
1
C. Hughes
1
C. Wilcox, L. Lebreton et al.
1
Cadernos de Saúde Pública
1
Camp, R. and C. Hoffmann
1
Cancer Association of South Africa (CANSA)
1
Cawthrope, D.
1
Center for Global Development
1
Central Research Institute of Epidemiology of Rospotrebnadzor
1
Centre for Antibiotic Resistance Research (CARe), University of Gothenburg
1
Chambliss, S. E.
1
Charles B. Nemeroff
1
Chaziya J, Freyne B, Lissauer S et al.
1
China CDC Weekly, CCDC Weekly
1
Chou-Zen Giam
1
Chu, D.K.
1
Cianconi, P.
1
Circulation
1
CMAM Forum
1
Cogent Medicine
1
Cole CP, James PB, Kargbo AT
1
College of American Pathologists
1
Consejo Nacional de Evaluación de la Política de Desarrollo Social (CONEVAL)
1
Convention on Biological Diversity
1
D. Gyamfi Amoako, R. Carrel Founou, et al.
1
D. Kerrigan
1
D. Luo
1
Dai, W., Kaminga, A.C., Tan, H., Wang, J., Lai, Z., Wu, X., Xiong, Y., Deng, J. & Liu, A.
1
DeFilipps, Robert A.
1
Department of Health Research Ministry of Health & Family Welfare
1
Desogus, A.
1
Deutsche Hauptstelle für Suchtfragen e.V.
1
Dèdonougbo Houenassi, M.
1
Dhan Bahadur Shrestha, Pravash Budhathoki, Bipana Gurung et al.
1
Dheda, K.
1
Doyle, M.P.
1
Dr. A. Wang
1
Dr. E. Emmett
1
E van‘t Hof, P Cuijpers, W Waheed, DJ Stein
1
E. Stevens
1
E.A Akl, S. Duda, et al.
1
Eckstein, D.
1
Ejembi, Clara Ladi, Tukur Dahiru, and Alhaji A. Aliyu
1
END TBc1
1
Environmental Science and Pollution Research
1
Espira, L. M.
1
Etienne V Langlois, Andrew Mc Kenzie, Helen Schneider & Jeffrey W Mecaskey
1
European Centers for Disease Control and Prevention ECDC
1
European Centre for Disease Prevention and Control ECDC
1
European Centre for Disease Prevention and Control (ECDC)
1
European Respiratory Journal, part of the European Respiratory Society (ERS)
1
Evangelina IN, Inês T, Miguelhete L et al
1
F. Zermoglio
1
Fajolu, I.
1
Ferres M., Potin M.
1
Fitzgerald, F.
1
Florian Lederbogen, Leila Haddad, Andreas Meyer-Lindenberg
1
Flying Publisher, Boehringer Ingelheim
1
Food and Agriculture Organization (FAO)
1
Fooks, A.
1
Founou, L.L.
1
Freedman, B.
1
Frontiers in Cardiovascular Medicine
1
G, Zambrano, E Salgato, F. M. Moyano et al.
1
G. H. Loneragan, H. M. Scott et al.
1
G. K. Siberry
1
G. S. Bel
1
Gabrys, J.
1
GBD 2019 Blindness and Vision Impairment Collaborator
1
GBD 2019 Blindness and Vision Impairment Collaborators
1
Germanwatch e.V.
1
Gil, A.
1
Gleeson, T.
1
Glenn, B. E.
1
Global Health Journal
1
Global Heart
1
Gojka Roglic, Cherian Varghese, Leanne Riley et al.
1
Grimshaw, J. M.
1
Gulani, A. & Sachdev, H.P.S
1
Gulev S. K., Thorne P. W. et al.
1
Guo Y., , Ye T., et al.
1
H. Kuper and K. Blanchett , et al.
1
H.L. Nguyen
1
Halaharvi, H.
1
Haute Conseil de la Santé Publique
1
Health Cluster
1
Hepatology Society of the Philippines
1
Hepatology Society of the Philippines (HSP)
1
Hindricks, G.
1
Hoffmann, C.
1
Hong‑Mei Luo
1
Hsia Y., B. R Lee, A. Versporten, et al
1
Hua Yu
1
Huffman, M. et al.
1
I. J. C. Schneider
1
I. Mokrousov, (St. Petersburg Pasteur Institute)
1
I. Semini
1
iMMAP
1
Imperial College COVID-19 Response Team
1
INTECH
1
International Diabetes Federation
1
International I nitiativ e for Impact E valuation (3ie)
1
International Primary Care Respiratory Group IPCRG
1
International Union Against Tuberculosis and Lung Disease, World Health Organization
1
IOP Science
1
IPAS
1
Iris (Institutional Repository)
1
J Family Med Prim Care
1
Jackson, J., Kheng Heng, L., Eklund, G. et al.
1
JAMIA Open
1
Janiri, L.
1
Jésuites d'Afrique de l'Ouest
1
Jing, Q.
1
Journal of Health Monitoring
1
Journal of the American College of Cardiology
1
Journal of the International AIDS Society
1
Julián-Jiménez, A.
1
K. P Msyamboza, L.Mawaya 2 , H.W Kubwalo, et al.
1
K.L.Ebi
1
Kakkar M., Chatterjee P. et. al.
1
Kalafs.S.
1
Kang Yiu Lai, Wing Yiu George Ng and Fan Fanny Cheng
1
Keymanthri Moodley, Kate Hardie, Michael J Selgelid, et al.
1
Kishimoto T., Robenzadeh A, Leucht C, et al.
1
Krupnick, Gary A.
1
Kumar Roy., S. and S. Bhattacharjee
1
L. Zhou
1
L.Houétondji Codjo, D. Dokoui, S, et al.
1
Ladnaya, N.
1
Larson, M. C.
1
Larson, P. S.
1
Lee, V.
1
Leufkens, H.G.M. et al.
1
Lockwod DN.
1
M. Dara, C. D. Acosta, M. V. S. Vinklers Melchers, et al.
1
M. F. Biudes
1
M. Fritzsche
1
M. G. Whitfield, H. M. Soeters, R. M. Warren, et al.
1
M. J. Abzug
1
M. Lefebvre
1
M. Mayan
1
M. Schomaker
1
M.-A. Davies
1
M.J. Nieuwenhuijsen, M. Gascon
1
Mailloux, N.A. et al.
1
Makanjuola, A. et al.
1
Makwe, C.
1
Mallick, Lindsay, Wenjuan Wang, Temsah, Gheda
1
Manas R. , Behera R., Satpathy S.K.
1
Mark, A.
1
Martinez Viciana, C.
1
Martínez-Austria Polioptro,F and Bandala E. R
1
McCaula, M.
1
McKee, M.
1
Medicine
1
Mensah, G.A.
1
Mental Health and Psychosocial Support Network
1
MHPSS.net
1
Minh D Pham
1
Ministerio da Saude Brasilia
1
Ministerio de Salud Argentina
1
Ministerio de Salud Chile
1
Ministerio de Salud Pública de Ecuador
1
Ministerio de Salud y Protección Social Bogotá, Colombia
1
Ministério da Saúde, Brazil
1
Ministério da Saúde, Secretaria de Atenção Primária à Saúde Brasil
1
Minja, N.W.
1
Morse, J.M.
1
Multidisciplinary Collaborative Group for the Scientific Monitoring of COVID-19 (GCMSC)
1
Mücke, H.
1
N. B Ilangaratne
1
N. N. Mannakkara
1
Nakagaayi, D.
1
Nalbandian, A.
1
National Department of Health, South Africa
1
Neil M Ferguson, Daniel Laydon, Gemma Nedjati-Gilani, Natsuko Imai, Kylie Ainslie, Marc Baguelin, Sangeeta Bhatia, Adhiratha Boonyasiri, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Ilaria Dorigatti, Han Fu, Katy Gaythorpe, Will Green, Arran Hamlet, Wes Hinsley, Lucy C Okell, Sabine van Elsland, Hayley Thompson, Robert Verity, Erik Volz, Haowei Wang, Yuanrong Wang, Patrick GT Walker, Caroline Walters, Peter Winskill, Charles Whittaker, Christl A Donnelly, Steven Riley, Azra C Ghani.
1
Neuron Review
1
Nkoa, F.C.
1
Nuffield Council on Bioethics
1
O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale)
1
Obago, Irene T
1
Oliveira e Souza, R.
1
OPAS, OMS
1
OPS
1
Organisation de la Santé Mondiale
1
Organisation Mondiale de la Santé (OMS)
1
Organización Mundial de la Salud (OMS)
1
Organización Mundial de Saude and OPAS
1
P. M. Enright, J. Shumake-Guillemot et al.
1
P. O. Zogo2
1
PAHO (Pan American Health Organization
1
Pan American Health Organization
1
Pan American Health Organization PAHO, World Health Organization WHO
A role for nuclear techniques
Antimicrobials play a critical role in the treatment of human and animal (aquatic and terrestrial) diseases, which has led to their widespread application and use. Antimicrobial resistance (AMR) is the ability of microorganisms to stop an antibiotic, such as an antimic...robial, antiviral or antimalarial, from working against them. Globally, about 700 000 deaths per year arise from resistant infections as a result of the fact that antimicrobial drugs have become less effective at killing resistant pathogens. Antimicrobial chemicals that are present in environmental compartments can trigger the development of AMR. These chemicals can also cause antibiotic-resistant bacteria (ARB) to further spread antibiotic resistance genes (ARG) because they may have an evolutionary advantage over non-resistant bacteria.more
The purpose of this document is to provide interim guidance to laboratories and stakeholders involved in laboratory testing of patients who meet the definition of suspected case of pneumonia associated with a novel coronavirus identified in Wuhan, China.
19 March 2020
This document provides guidance on the application of non-pharmaceutical countermeasures to minimise the spread of the 2019 novel coronavirus (2019-nCoV) in the population. Some of the measures proposed refer specifically to certain phases of the epidemic (containment or mitigation phases), and can ...be adapted depending on the assessed severity/impact of the infection. Other measures are valid for all phases of an epidemic.
The guidance is based on the current knowledge of the 2019-nCoV and evidence available on other viral respiratory pathogens, mainly the Severe Acute Respiratory Syndrome coronavirus (SARS-CoV), the Middle East Respiratory Syndrome-related coronavirus (MERS-CoV) and seasonal or pandemic influenza viruses.more
Всемирная организация здравоохраненияВсемирная организация здравоохранения (Европа); European Centre for Disease Prevention and Control (ECDC)
(2018)
C_WHO
ДОПОЛНЕНИЕ
СЛУГИ ТЕСТИРОВАНИЯ НА ВИЧ
ДЕКАБРЬ 2016 г.
MICROBIAL DRUG RESISTANCEVolume 24, Number 5, 2018ªMary Ann Liebert, Inc.DOI: 10.1089/mdr.2017.0383
Antibiotic resistance (ABR) is a worldwide publichealth concern, with serious health, economic, and so-cietal repercussions. Its emergence is attributed to the se-lective pressure exerted by antib...iotic use in the community, hospitals, veterinary health, agriculture, aquaculture, and the environment. Additionally aggravating the situation is the fact that very few new antibiotics have recently been produced by pharmaceutical companies. It is widely acknowledged that food animals are key reservoirs of antibiotic-resistant bacteria and that antibiotic usage in this population favors the emergence, selection, and spread of resistance among animals and humans, both through zoonoses (infectious diseases trans-mitted between animals and humans) and the food chain.more
Comprehensive Reviews in Food Science and Food Safety, Vol.12 (2013) pp.234-248
In 2006, the Institute of Food Technologists (IFT) published an Expert Report entitled “Antimicrobial Resistance: Implications for the Food System” (IFT 2006). That report summarized current scientific knowledge pe...rtaining to the public-health impact of antimicrobial use in the food system and the development and control of antimicrobial resistance. Since that time, intense interest in this topic has continued within the regulatory and scientific communities as well as the general public. This IFT Scientific Status Summary serves to update that 2006 IFT Expert Report by briefly reviewing new scientific evidence relevant to the goals of the initial report and providing a number of key observations and conclusions.more
The systematic surveillance of antibiotic use and antibiotic re-sistance prevalence in humans and animals is imperative for managingbacterial infectious disease (JPIAMR, 2019;WHO, 2015). Many low-income countries currently face substantial challenges in building national surveillance systems due to ...a lack of infrastructure and resources,resulting in a shortage of systematic data (FAO/OIE/WHO, 2018)more
La evolución de los acontecimientos y el esfuerzo conjunto de la comunidad científica mundial, hangeneradogran cantidad de información que se modificarápidamente con nuevas evidencias. Este documento pretende hacer unresumen analítico de la evidencia científica dispo...niblehasta el momento en torno a la epidemiología, características microbiológicas y clínicas del COVID-19.En esta actualización se añaden los hallazgos acerca de la transmisiónen periodo asintomático y a partir de aerosoles y superficies inanimadas, así como las características de los principales grupos de riesgo. Para información relativa a medicamentos relacionados con COVID-19 se puede consultar la web de la Agencia Española del Medicamento y ProductosSanitarios: https://www.aemps.gob.es/more
La Agencia Española de Medicamentos y Producto Sanitarios (AEMPS) está monitorizando de manera continua con los expertos de las agencias europeas, la EMA y el resto de agencias mundiales todos los datos relativos al uso de medicamentos para tratar la COVID-19. Se trata de... un escenario que puede ir cambiando por la enorme cantidad de datos, comunicaciones y publicaciones que se están generando a nivel mundial. El presente documento técnico tiene la finalidad de guiar el manejoclínicode los pacientes conCOVID-19 con un doble objetivo: lograr el mejor tratamiento del paciente que contribuya a su buena evolución clínica; y garantizar los niveles adecuados de prevención y control de la infección para la protección de los trabajadores sanitarios y de la población en su conjunto.more
El presente documento técnico tiene la finalidad de guiar el manejode cuidados intensivosde los pacientes conCOVID-19 con undoble objetivo: lograr el mejor tratamiento del paciente que contribuya a subuena evolución clínica; ygarantizar los niveles adecuados de prevención y control de la... infección para la protección de los trabajadores sanitarios y de la población en su conjunto.more
Se sabe que las mujeres embarazadas experimentan cambios inmunológicos y fisiológicos que pueden hacerlas más susceptibles a las infecciones respiratorias virales, incluido COVID-19. Varios estudios revelaron que las mujeres embarazadas con diferentes enfermedades resp...iratorias virales tenían un alto riesgo de desarrollar complicaciones obstétricas y resultados adversos perinatales en comparación con las mujeres no grávidas, debido a los cambios en las respuestas inmunes. También sabemos que las mujeres embarazadas pueden estar en riesgo de enfermedad grave, morbilidad o mortalidad en comparación con la población general, tal y como se observa en los casos de otras infecciones por coronavirus
5relacionadas [incluido el coronavirus del síndrome respiratorio agudo severo (SARS-CoV) y el coronavirus del síndrome respiratorio del Medio Oriente (MERS-CoV)] y otras infecciones respiratorias virales, como la gripe, durante el embarazo.more
This interim guidance has been updated with advice on safe and appropriate home care for patients with coronavirus disease 2019 (COVID-19) and on the public health measures related to the management of their contacts.
Internationally, there is a growing concern over antimicro-bial resistance (AMR) which is currently estimated to ac-count for more than 700,000 deaths per year worldwide. If no appropriate measures are taken to halt its pro-gress, AMR will cost approximately 10 million lives andabout US$100 trillion... per year by 2050. In contrast tosome other health issues, AMR is a problem that con-cerns every country irrespective of its level of incomeand development as resistant pathogens do not respect borders.Despite the threat presented by AMR, the 2014 WorldHealth Organization (WHO) and the recent O’Neill re-port describe significant gaps in surveillance, standardmethodologies and data sharing. The 2014 WHOreport identified Africa and South East Asia as the regions without established AMR surveillance systems.
Tadesseet al. BMC Infectious Diseases (2017) 17:616 DOI 10.1186/s12879-017-2713-1more
Improving the quality of hospital antibiotic use is a major goal of WHO’s global action plan to combat antimicrobial resistance. The WHO Essential Medicines List Access, Watch, and Reserve (AWaRe) classification could facilitate simple stewardship interventions that are widely applicable globally.... We aimed to present data on patterns of paediatric AWaRe antibiotic use that could be used for local and national stewardship interventions.
www.thelancet.com/lancetgh Vol 7 July 2019more
Pakistan Global Antibiotic Resistance Partnership (GARP) was formed in the wake of international and national efforts for AMR curtailment. A group of experts from microbiology, infectious diseases and veterinary medicine formed a core group at the organizational meet...ing of GARP in Kathmandu, Nepal in July 2016. In the meeting, this core group was expanded to include other members from different sectors with the selection of the Chair and co-chairs. These were asked to serve on a voluntary basis, in their own individual capacities, with no personal gains, or gains to the institutions to which they are affiliated. The first phase of GARP took place from 2009 to 2011 and involved four countries: India, Kenya, South Africa and Vietnam. Phase one culminated in the 1st Global Forum on Bacterial Infections, held in October 2011 in New Delhi, India. In 2012, phase two of GARP was initiated with the addition of working groups in Mozambique, Tanzania, Nepal and Uganda. Phase three has added Bangladesh, Lao PDR, Nigeria, Pakistan and Zimbabwe to the network to date.more